Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein is a research paper published in Frontiers in Neurology (2020). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01-108686
National Institutes of Health
Grant: R01-AG044342
National Institutes of Health
Grant: R01-AG05882
National Institutes of Health
Grant: R01-NS086074
National Institutes of Health
Grant: R01-NS092093
National Institutes of Health
Grant: R56-NS113549
National Institutes of Health
Grant: 1F32AG005882-01
THE NEUROBIOLOGY OF CORTISTATIN
National Institutes of Health
Grant: 5R01DK108686-04
Effect of Treatment Dose on Childhood Obesity
National Institutes of Health
Grant: 5R01AG058820-05
Preventing Seizures and Associated Memory Loss in Alzheimer's Disease by Blocking Tau Interactions with SH3-containing Proteins.
National Institutes of Health
Grant: 5R01NS086074-05
Unfolded Protein Response in Alpha-synucleinopathies
National Institutes of Health
Grant: 5R01NS092093-02
Pathological role of c-Abl in alpha-synucleinoapathy
National Institutes of Health
Grant: 1R01AG044342-01A1
Soluble aSyn is a modulator of AD pathophysiology
National Institutes of Health
Grant: 1R56NS113549-01
Role of alpha-synuclein-dependent network hyperactivity in Lewy Body Dementia
FWCI
1.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals